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Abstract
Connexins constitute a large family of trans-membrane proteins that allow intercellular
communication and the transfer of ions and small signaling molecules between cells. Recent studies
have revealed complex translational and post-translational mechanisms that regulate connexin
synthesis, maturation, membrane transport and degradation that in turn modulate gap junction
intercellular communication. With the growing myriad of connexin interacting proteins, including
cytoskeletal elements, junctional proteins, and enzymes, gap junctions are now perceived, not only
as channels between neighboring cells, but as signaling complexes that regulate cell function and
transformation. Connexins have also been shown to form functional hemichannels and have roles
altogether independent of channel functions, where they exert their effects on proliferation and
other aspects of life and death of the cell through mostly-undefined mechanisms. This review
provides an updated overview of current knowledge of connexins and their interacting proteins,
and it describes connexin modulation in disease and tumorigenesis.
Introduction
A cell in its normal physiological context within a tissue
perceives micro-environmental cues from soluble media-
tors, extracellular matrix (ECM), and neighboring cells.
Adhesion molecules mediating cell-cell and cell-ECM
interactions are multifunctional, providing structural sup-
port and links between the cell and its environment, and
also organizing the cell's cytoskeleton as well as initiating
and integrating signaling cascades [1,2].
Disruption of adhesion complexes, mainly adherens junc-
tions, tight junctions, and gap junctions, leads to interfer-
ence with normal tissue function, and may eventually
lead to tumor development [3]. The adherens and tight
junctions have been studied as independent entities, and
together as key components of the apical junctional com-
plex which regulates paracellular permeability (barrier
function) and cell polarity, among other functions [4].
Among cell-cell adhesion molecules, intercellular com-
munication by gap junctions is paramount for maintain-
ing cellular homeostasis and function [5,6]. Connexins
and connexin-like proteins, in vertebrates and inverte-
brates, pannexins and innexins, are proteins capable of
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forming gap junctions [7]. Twenty different connexin
genes have been found in mice and 21 in humans [8], and
these,  via  formation of gap junctions, allow direct
exchange of small molecules between adjacent cells,
including important signaling molecules such as Ca2+,
IP3, and more recently siRNA [9,10]. Connexin structure
is highly conserved; however certain cytoplasmic domains
show variability between different isoforms and allow for
different interactions and functions. The known repertoire
of connexin associated proteins has recently expanded,
and includes cytoskeletal elements, enzymes (kinases and
phosphatases), adhesion molecules, and signaling mole-
cules [11]. These connexin-associated proteins regulate
and mediate both channel-dependent and -independent
functions of connexins. In addition, connexin mutations,
altered expression, and impaired gap junction function
are characteristic of some diseases and neoplasms [12,13].
In this review, we present an updated overview of connex-
ins, as well as the rapidly expanding list of connexin-asso-
ciated proteins. We also discuss the various connexin
functions, whether these are channel dependent or inde-
pendent, and we attempt to document the inter-relation-
ship between the connexin-associated proteins and these
functions. In addition, we reveal the impact of disruption
of gap junction and connexin function on the process of
disease and cancer development.
The connexin family
Gap junctions are clusters of channels that join two cells
together and consist of building blocks of two connexons
or hemichannels, one contributed by each of the commu-
nicating cells. Each connexon or hemichannel is formed
of a complex of six connexin proteins. Such junctions
allow intercellular exchange of molecules less than 1.5
kDa in molecular weight [14,15]. Most cells of normal tis-
sue, except skeletal muscle cells, erythrocytes, and circulat-
ing lymphocytes, communicate via gap junctions. This is
an indication of the pivotal roles that proper connexin
gene expression, protein levels, and protein function play
in regulating various physiological phenomena including,
growth, differentiation, developmental signaling, and cell
death [5,16-18].
Connexin gene
Most connexins, with very few exceptions [19], share a
common gene structure, consisting of two exons sepa-
rated by one intron sequence. The intron, which is of var-
iable length, is situated within the 5'-untranslated region,
while the second exon contains the connexin coding
sequence, and the 3'-untranslated region [20]. In noted
exceptions, the coding sequence is interrupted by introns,
and this is observed in a few mouse and human connex-
ins. In addition, connexin genes may have different tissue-
specific promoter usage patterns resulting in different
transcription start sites and a different 5'-UTR [8].
The sequencing of connexin genes began in the 1980s,
and most of the remaining, rodent and human connexin
genes, were sequenced in recent years. Evolution studies
on connexin sequences have shown that they are chor-
date-specific and highly conserved [21,22]. Invertebrates
do not express connexins and display direct cell-cell com-
munication via a family of proteins termed innexins,
which play a connexin-like role, even though they lack
sequence homology to connexins [23,24]. Pannexin
genes, innexins homologues, have since been discovered
in the genomes of higher vertebrates, including humans,
where they are expressed in a variety of tissues, with seem-
ingly significant functions, most notable in the brain and
in mediating immune response to pro-inflammatory
stimuli through ATP-dependent activation of the inflam-
masome complex [7,25].
The various connexin isoforms are differentially-
expressed, displaying spatial and temporal specificity
modulated by a variety of transcription factors, including
the Sp transcription factors (Sp1 and Sp3), Activator pro-
tein 1 (AP-1), as well as members of the Jak/STAT pathway
[26,27]. In addition, other cell type specific transcription
factors regulate connexin gene expression and these
include Nkx2, HNF-1, Mist1, NFKB and others [27,28]. In
the past few years it has also become apparent that epige-
netic processes are involved in regulating connexin gene
expression. In addition to histone modifications and
DNA methylation, recently, microRNA species have been
reported as key regulators of Cx expression [29,30].
Connexin protein
The connexin protein is composed of nine main domains,
of which the N-terminus, the two extracellular loops (sta-
bilized by intramolecular disulfide bridges), and the four
transmembrane domains are highly conserved among dif-
ferent isoforms. In contrast, the cytoplasmic loop domain
and the C-terminus domain are divergent and variable in
length and sequence, allowing for the functional differ-
ences among the different connexins and the connexon
types [31-33]. The N-terminus, cytoplasmic loop, and C-
terminus are located in the cytosol, and this allows for the
interaction of these domains, the C-terminal domain in
particular, with connexin-interacting proteins such as cat-
enins and others, which are essential for modulating con-
nexin half-life, activity and functions [11]. The connexin
nomenclature is according to one of two systems: (i) The
first is based on a "number" system whereby the molecu-
lar weight predicted from the cDNA sequence of the con-
nexins denotes the type of the connexin. For example,
Cx26, Cx32, Cx43 refers to the connexins with molecular
weight 26 kDa, 32 kDa and 43 kDa respectively [34], and
(ii) the second is based on sequence similarity and length
of the cytoplasmic domain of the connexins, thereby clas-
sifying them into α, β, and γ subgroups [35]. In this latter
the connexins are designated as "GJ" for gap junction andCell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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serially numbered in the order of their discovery within
each subgroup. For example, Cx43 was the first connexin
discovered in the α subgroup and was designated as Gja1,
while Cx32 was the first in the β subgroup and was desig-
nated as Gjb1. However, until recently there were discrep-
ancies between both nomenclatures. Further alignment
between the two nomenclature systems, to alleviate the
discrepancies, was recommended [36], and later adopted.
Synthesis and maturation
Connexins are typically translated into polypeptide
sequences by ribosomes attached to the endoplasmic
reticulum (ER), similar to other transmembrane proteins,
followed by sequential release of the protein (co-transla-
tionally) into the ER lumen through the Sec61 or translo-
con, until completion of translation [37,38]. This is
followed by the folding of the connexin protein while still
in the ER.
Connexons are formed of six connexin proteins, which
assemble into a hemichannel with either identical con-
nexin subunits (homomeric) or different connexins
(heteromeric). In addition, gap junctions may be homo-
typic, when two identical connexons assemble, or hetero-
typic, when two dissimilar connexons assemble between
the two interacting cells. Since many cells express multiple
connexin isoforms, the possibility of heteromeric con-
nexon hemichannels is highly significant in raising the
number of potential combinations of the approximately
twenty available connexin types. Also, channels formed of
heteromeric connexons have different properties from
those of homomeric channels of the constituent connex-
ins, and the properties of such heteromeric channels can
be manipulated by regulating the ratio of constituent con-
nexins, thereby allowing for critical regulation of the per-
meability and conductance of gap junctions [39]. It has
been suggested that C-terminal peptide sequences in con-
nexins may act as assembly signals regulating principal
connexin subunit recognition; moreover a selectivity sig-
nal regulating specific assembly of heterotypic connexons
is located in the amino-terminus (at the first transmem-
brane domain or the first extracellular loop) of the con-
nexin polypeptide sequence [38]. Thus, the control of
connexin oligomerization occurs at two levels, the struc-
tural compatibilities of the connexin types, and the cellu-
lar mechanisms that may interfere in the interaction
between compatible connexins [40].
Connexin oligomerization into connexons was initially
reported to occur in the ER, however, some exceptions
have been shown in which connexins remain in the mon-
omeric form (i.e. single connexin proteins) upon reaching
the Golgi apparatus where they oligomerize into connex-
ons [41,42]. Therefore, it has been suggested that con-
nexin oligomerization occurs sequentially throughout the
transport of the connexins within the ER till the trans-
Golgi network, where oligomerization is completed (Fig-
ure 1) [13,38]. An exception to this pathway is Cx26
which may be either co- or post-translationally trans-
ported into the ER [43] or directly to the plasma mem-
brane [44], without passing through the Golgi apparatus
[45].
Life cycle and protein associations of connexins Figure 1
Life cycle and protein associations of connexins. Con-
nexins are synthesized on ER-bound ribosomes and inserted 
into the ER cotranslationally. This is followed by oligomeriza-
tion between the ER and trans-Golgi network (depending on 
the connexin type) into connexons, which are then delivered 
to the membrane via the actin or microtubule networks. 
Connexons may also be delivered to the plasma membrane 
by direct transfer from the rough ER. Upon insertion into the 
membrane, connexons may remain as hemichannels or they 
dock with compatible connexons on adjacent cells to form 
gap junctions. Newly delivered connexons are added to the 
periphery of pre-formed gap junctions, while the central 
"older" gap junction fragment are degraded by internalization 
of a double-membrane structure called an annular junction 
into one of the two cells, where subsequent lysosomal or 
proteasomal degradation occurs, or in some cases the con-
nexons are recycled to the membrane (indicated by dashed 
arrow). During their life cycle, connexins associate with dif-
ferent proteins, including (1) cytoskeletal components as 
microtubules, actin, and actin-binding proteins α-spectrin and 
drebrin, (2) junctional molecules including adherens junction 
components such as cadherins, α-catenin, and β-catenin, as 
well as tight junction components such as ZO-1 and ZO-2, 
(3) enzymes such as kinases and phosphatases which regulate 
the assembly, function, and degradation, and (4) other pro-
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Transport to the cell membrane
Upon completion of connexin oligomerization, con-
nexon hemichannels are packaged into vesicles (between
the ER and the trans-Golgi network) and delivered to the
membrane. This connexon transport may either be micro-
tubule dependent or independent, and these include
actin-mediated transport as well as other unidentified
mechanisms [38,46-48]. Even though connexon insertion
in the plasma membrane has been suggested to be ran-
dom, microtubules may mediate targeting of these gap
junction hemichannels to specific membrane domains or
regions, especially those containing adherens junction
components [49].
Following connexon insertion into the plasma mem-
brane, the hemichannel may remain uncoupled, where it
has been shown to play possible roles in the life of the cell
[50]. However, the common pathway is for inserted and
apposing connexons to interact via  their extracellular
loops to form intercellular channels. The individual chan-
nels aggregate in the membrane to form plaques, and
these are termed gap junctions (Figure 1) [51].
Post-translational modifications
Connexins may undergo various types of post-transla-
tional modifications, including phosphorylation, hydrox-
ylation, acetylation, disulfide binding, nitrosylation, and
palmitoylation [52-55]. The most studied of these con-
nexin post-translational modifications is phosphoryla-
tion of connexins on various residues. These
phosphorylation events are essential in the proper control
of formation and modulation of function of gap junction
channels, and they have been observed in at least nine
connexins (Cx31, Cx32, Cx37, Cx40, Cx43, Cx45, Cx46,
Cx50, and Cx56), while others, such as Cx26 remain
unphosphorylated. Connexin phosphorylation by differ-
ent kinases such as Src, PKC, and MAPKs is required for
and affects connexin/connexon trafficking, assembly and
disassembly, degradation, and gating (rapid opening and
closing) of gap junction channels [56,57]. The effect of
phosphorylation on channel gating is very specific, as the
phosphorylation of a connexin isoform such as Cx43 on
different residues by the same kinase may lead to opposite
effects with respect to enhancing or inhibiting gap junc-
tion function or gap junction intercellular communica-
tion (GJIC) [18]. The phosphorylation events also affect
other cellular functions of connexins that are independent
of gap junctions, including the control of growth and pro-
liferation (These are elaborated upon in section III of this
review).
In addition, the association of connexins with other inter-
acting proteins also plays an important role in the stability
and function of gap junctions [11,58].
Half life and degradation
Since connexin proteins have a very short half-life not
exceeding few hours, the synthesis and delivery to the
membrane of new connexin proteins is coupled to simul-
taneous gap junction internalization and connexin degra-
dation [38,59]. It has been suggested that newly delivered
connexons localize to the periphery of existing gap junc-
tional plaques, whereas the "old" connexons that are to be
degraded are usually present at the center of the gap junc-
tional plaque [60].
The mechanism of gap junctional internalization is
through the formation of annular junctions, which are
large double-membrane vesicular structures that could
contain the entire gap junction, or a fragment of it, and
transport it, from cell-cell boundaries, into one of the two
interacting cells [13,61]. Following gap junction internal-
ization, these complexes undergo preliminary degrada-
tion in the annular junctions, leading to disassembly of
gap junctions and connexons into individual connexins
[62]. The connexin proteins undergo complete degrada-
tion through either proteasomes or lysosomes, with each
of the two degradation pathways having different roles. As
such, the proteasome degradation pathway may regulate
connexin stability and internalization from the cell mem-
brane, but this effect is suggested to be indirect, possibly
through regulating the turnover of Cx-associated proteins,
such as ZO-1 [63,64]. On the other hand, lysosomal deg-
radation plays a more central role in connexin protein
degradation, either before transport to the membrane or
after incorporation in the membrane but before the for-
mation of functional gap junctions [13,38,64,65].
Connexin associations
Connexon docking and channel assembly at the cell sur-
face is the preliminary step towards proper cellular com-
munication and formation of gap junctions. However,
connexin proteins do not act in isolation in gap junctional
complexes, but rather interact with many associated pro-
teins that play essential roles in regulating the assembly,
function, and life-span of connexins [11,58].
The number and diversity in connexin associating part-
ners has increased steadily over the past years, implicating
tight and adherens junctional proteins in the complex, as
well as protein phosphatases and kinases, in addition to
cytoskeletal elements, in the regulation and control of the
gap junction complex [11,18,51,58,66,67]. The main
interacting partners of connexin proteins are cytoskeletal
elements, junctional proteins, and enzymes (Figure 1).
As connexin 43 is the most studied connexin protein, due
in part to its expression in a wide variety of different tis-
sues, it was of inherent interest to study its interactions
with cytosolic proteins. The C-terminal region of Cx43Cell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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can interact with many proteins, including kinases, phos-
phatases, membrane receptors, cell signaling and scaffold-
ing proteins. The N-terminal, cytoplasmic loop, and some
membrane-spanning domains of connexins also interact
with a variety of proteins, some of which bind the C-ter-
minus as well [11,66].
Connexin interactions with cytoskeletal elements
Interactions of connexins with cytoskeletal elements are
essential in transporting connexins to the membrane and
providing a mean for their rapid turnover and replenish-
ment.
Microtubules
Co-immunoprecipitation experiments revealed that Cx43
sediments with microtubules and bioinformatics analysis
confirmed this result by unraveling a tubulin-binding
domain (234KGVKDRVKGL243) in Cx43 [68]. It has been
confirmed that Cx43 directly binds to α- and β-tubulin
and that microtubules at the cell-periphery co-localize
with Cx43-based gap junctions. The 35 juxtamembrane
amino acids of the C-terminal tail were found to be neces-
sary and sufficient for this interaction [68,69]. Further-
more, multiple alignment studies from our laboratory
[18] have revealed a tubulin-binding site in connexin 46
and in xenopus oocyte connexin 41[70].
This interaction of connexin proteins with microtubules
has been shown to be essential in allowing directed trans-
port of newly synthesized connexin hemichannels to the
plasma membrane. That microtubules also interact with
other junctional molecules such as cadherins allows
increased specificity in the targeting of connexins to the
adherens junction, and this directs the delivery of newly-
synthesized connexons to areas of pre-existing adherens
junctions [49].
Actin,  -spectrin, and drebrin
Interactions of connexins with the actin cytoskeleton and
associated proteins serve to stabilize gap junctions at the
plasma membrane. Immuno-histochemical analysis has
shown that Cx43 and actin colocalize in a variety of cell
types [71]. In addition, studies have shown that the mem-
brane cytoskeletal protein, α-spectrin co-precipitates with
gap junctional complexes, possibly via interaction with
ZO-1 [72]. The existence of various isoforms of α-spectrin
requires functional studies of each with respect to their
effect on gap junction function. For example, an alterna-
tively spliced αII-spectrin isoform has been shown to play
a role in transducing stress-induced signaling by forming
a physical link between JNK stress-induced signaling path-
way, and GJ function, to influence intercellular communi-
cation under stressful conditions [73].
A novel connexin-interacting cytoskeletal protein is
drebrin ("developmentally regulated brain protein"), an
actin-binding protein involved in mediating cellular
polarity and formation of stabilized plasma membrane
domains [74], which has been shown to interact with the
carboxy-terminal end of Cx43. This interaction allows the
stabilization of Cx43 gap junctions at the membrane, and
as such may control its life cycle, as siRNA depletion of
drebrin led to the inhibition of cell coupling, and to inter-
nalization and degradation of Cx43 [75].
Connexin interactions with junctional proteins
The interaction between gap junctional proteins and pro-
teins of the adherens and tight junctions is a clear indica-
tion of the interplay between these cell adhesion
complexes. The inter-connectedness between the three
junctional complexes, both direct interactions and indi-
rect interactions through their associated proteins, has
given rise to the concept of formation of large protein
intercellular complexes containing multiple junctional
molecules. The interaction between connexins and other
adhesion proteins might be involved in regulating con-
nexin assembly, trafficking, turnover and channel gating,
in that these complexes may form a regulatory backbone
for various stages of the connexin life cycle, including
membrane insertion, localization, and gap junctional
plaque formation [11,58].
Interactions with tight junction proteins
Studies have shown that several growth factors that regu-
late GJIC also regulate tight junction permeability, while
others have shown that connexins and tight junction tet-
raspan membrane core proteins, claudins and occludins
[76,77] co-immunoprecipitate, and that gap junctions
may even regulate the expression and function of tight
junction proteins [11,58,78-80].
ZO-1 and ZO-2
The tight junction membrane-associated guanylate kinase
protein, zonula occludens-1 (ZO-1) is involved in the
organization and trafficking of gap junctions. In a study
by Laing et al. [81], ZO-1 was shown to regulate Cx43-
mediated gap junctional communication in osteoblastic
cells by altering the membrane localization of Cx43. The
study suggested that ZO-1 mediates the delivery of Cx43
from a lipid raft domain to gap junctional plaques, which
is an important regulatory step in gap junction formation.
The C-terminal residues of Cx43 and Cx45 interact with
the second PDZ domain of ZO-1, and this binding can
recruit regulatory proteins into the gap junctions
[63,69,82-84]. Another potential role for the interaction
of ZO-1 with Cx43 is to act as a scaffold for other proteins,
thereby bringing them into close contact with either the
gap junction proteins themselves or with molecules that
pass through the gap junction plaques. For example, ZO-
1 can bind to catenins in epithelial cells and act as an
adapter for the transport of connexin 43 during gap junc-
tion formation [85]. Barker et al. [86] revealed that associ-Cell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
Page 6 of 17
(page number not for citation purposes)
ation between ZO-1 and Cx43 is increased during
remodeling of cardiac gap junctions, possibly implicating
ZO-1 in gap junction turnover during cardiac develop-
ment and possibly during disease progress. In addition to
Cx43, other connexins encode putative PDZ binding
sequences at their C-termini, raising the possibility that
other Cx's might be associating with ZO-1 [11,87].
Moreover, another connexin, Cx32, colocalizes with tight
junction proteins ZO-1 and ZO-2 in rat hepatocytes, and
small gap junction plaques were found within tight junc-
tion strands. It was suggested that Cx32 can participate in
the formation of functional tight junctions and in actin
organization [78]. Recently our laboratory has shown that
Cx30, Cx32, and Cx43 associate with ZO-2, as well as
other Cx-associated proteins, during mammary epithelial
cell (MEC) differentiation, and that these associations are
crucial for MEC differentiation [88].
Furthermore, the associations between Cx43 and ZO-1
and ZO-2 proteins were shown to be under cell-cycle
stage-specific control. Connexin 43 interacts preferentially
with ZO-1 during G0 stage, whereas the interaction with
ZO-2 is approximately the same during the various stages
[89]. This may signify a greater level of complexity in the
connexin-zonula occludens interactions and their impact
on cellular functions.
Occludin and claudin
Occludin, like the connexins, is also a four transmem-
brane domain protein. Recent studies using cultured
hepatocytes showed that occludin is also associated, and
co-immunoprecipitates, with gap junctional proteins, in
particular connexin 32 [77]. Examination of freeze-frac-
ture replicas of these cells shows many small gap junc-
tional plaques localized near tight junctional strands, and
co-immunoprecipitation studies on cultured hepatocytes
western blotted with Cx32 provided evidence for an asso-
ciation between occludin and Cx32 [51]. Cx26 has also
been reported to interact with occludin in polarized sheets
of the human intestinal cell line T84 [90]. An additional
tetraspan family of proteins, the claudins, has also been
found to associate with connexins. Kojima et al. [77]
found that along with an association with occludin, Cx32
also associated with claudin-1 in hepatocytes, while Cx26
[91] has been shown to colocalize with claudin-14 in
human airway epithelial cell lines and to have a gap junc-
tion-independent role in maintaining the proper func-
tioning of tight junctions.
Interactions with adherens junction proteins
Since it was established that important cellular processes
such as cell proliferation and growth are partly regulated
by connexin-cadherin interactions, and with the notion
that connexins modulate adherens junction formation,
and adherens junctions participate in gap junctional
assembly [92], it has become pivotal to study connexin-
adherens junction associations. This intimate linkage
between gap junction and adherens junction formation
reflects the close membrane-membrane apposition
required for junction formation. It also provides evidence
for the assembly of multi-adhesion molecule complexes
between cells and how that mediates proper intercellular
interactions in tissues to allow enhanced and optimal sig-
naling between cells.
Cadherins
A number of reports addressed connexin co-localization
with cadherin proteins. Wei et al. [93] reported the co-
localization and co-immunoprecipitation of Cx43 protein
with N-cadherin, p120 and other N-cadherin associated
proteins at regions of cell-cell contact. Matsuda et al. [94]
also showed an association between Cx43 and N-cad-
herin, and this interaction required Rac1 and RhoA-medi-
ated signaling downstream of N-cadherin membranous
localization, leading to targeted connexin delivery and
insertion at the membrane. Moreover, the upregulation of
E-cadherin-dependent cell-cell contacts increased GJIC in
mouse epidermal cells [95], while anti-N-cadherin anti-
bodies prevented both adherens junctions formation and
GJIC [92]. A study by Xu et al. [96] revealed that associa-
tion between cadherins and connexins is not only impor-
tant for structural purposes, but that gap junction
mediated dye coupling is inhibited in a knock-out N-cad-
herin mouse model.
Recently, Huang et al. [97] demonstrated linkage between
adherens and gap junctions by treatment of rat adenocor-
tical cells with 18 -glycyrrhetinic acid, a gap junction
inhibitor. This treatment reduced the immunoreactivity of
these proteins in a time- and dose-dependent manner,
and caused the gap junction and adherens junction to sep-
arate longitudinally from the cell-cell contact sites, indi-
cating the structural interdependency of these two
junctions.
Catenins
Cx43 interacts with  -catenin, a versatile protein with
adhesive and transcriptional functions, and the connexin-
-catenin complex colocalizes mainly at the cell mem-
brane. This finding [98] raised the question as to whether
Cx43 is regulating  -catenin signaling by sequestering it at
the membrane. The ability of Cx43 to modulate  -catenin
signaling suggests that connexins, in addition to their clas-
sical channel forming role, might be involved in regulat-
ing cell growth by yet another mechanism. For example,
p120 catenin-related protein was co-localized with Cx43
and N-cadherin in mouse neural crest cells [96]. In addi-
tion, both E-cadherin and α-catenin were co-localized
with Cx26 and Cx32 during gap junction reappearance inCell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
Page 7 of 17
(page number not for citation purposes)
mouse hepatocytes [99]. Connexins 30, 32, and 43 have
been shown to associate with both α-catenin and  -catenin
in mammary epithelial cells, and this interaction was pro-
posed to sequester  -catenin away from the nucleus in dif-
ferentiation-permissive conditions [88]. In addition to the
documented interaction of  -catenin with connexins, and
its implications for regulating function, studies suggest a
role for α-catenin/Cx43 interaction in the assembly and
trafficking of the gap junction proteins to the membrane
[100].
Given that N-cadherin and catenins are co-assembled in
the endoplasmic reticulum and Golgi compartments, and
in the light of reported interaction of Cx43 with the
former proteins, the possibility of Cx43 assembly as part
of a multi-protein complex that regulates gap junction
and adherens junction formation is raised and future
studies are needed to address this question.
Connexin interactions with enzymes
The post-translational modification of connexin proteins,
mostly represented by phosphorylation processes, implies
that connexins interact significantly with various protein
kinases, as well as phosphatases. This phosphorylation is
essential for a variety of the connexin family members
during their assembly into gap junctions [101]. It has also
been noted that gap junctional communication may be
suppressed by the action of a number of protein kinases,
growth factors and oncogenes, and that this suppression
correlates often with mitogenesis [102].
Tyrosine kinases
Studies have shown that Cx43 is a v-Src substrate [103].
Mutation of the putative v-Src phosphorylation site results
in lack of gap junction closure by v-Src in Xenopus oocytes
[104]. Further studies showed that phosphorylated
Tyr265 in Cx43 forms a docking site for the SH2 domain
of v-Src and that the SH3 domain of v-Src can bind to a
proline rich stretch in Cx43 [105]. In addition, Tyr247 can
be phosphorylated by v-Src. Accordingly, a model was
proposed in which (i) v-Src binds to Cx43 via  a SH3
domain/proline-rich motif association; (ii) Src then phos-
phorylates Cx43, mainly on Tyr265; and (iii) subsequent
docking of the SH2 domain of Src to Cx43 Tyr265
increases affinity and positions Src for (iv) Tyr247 phos-
phorylation leading to channel closure [106]. Other
reports by Giepmans et al. [107] and Toyofuku et al. [82]
also revealed that Tyr265 phosphorylation by c-Src is
most likely involved in interaction of Cx43 with ZO-1.
Moreover, phosphorylated Cx43 binds to c-Src via  the
SH2 domain, competing with ZO-1 binding to the con-
nexin protein [82,106].
Serine/threonine kinases
The involvement of serine/threonine kinases in gap junc-
tion regulation has also been well documented. For exam-
ple, PKC acts on Ser368 of Cx43, resulting in inhibition of
GJIC [57]. Interestingly, PKCε, which has been implicated
in inhibition of GJIC downstream of the fibroblast growth
factor-2, has been reported to co-immunoprecipitate and
co-localize with Cx43 in cardiomyocytes [108]. Similar
results have been described for the PKCγ isotype acting
downstream of the insulin-like growth factor receptor-I
[109]. However, an upregulation of GJIC occurs by PKCα
concomitant with Cx43 phosphorylation [110], and as
such, maximal Cx43 phosphorylation and GJIC are
observed during mammary gland differentiation and lac-
tation [111,112]. Another study by Seo et al. [113] showed
that Cx 26, 32, and 43 are regulated by MAP kinases dur-
ing differentiation of rat mammary epithelial cells. Inter-
estingly, MAPK was shown to interact with Cx43 and
mediate its phosphorylation, however, the effect of this
phosphorylation on gap junction gating and function
remains controversial [80]. The seemingly contradictory
effects of PKCs on Cx43 and GJIC likely reflect the com-
plexity of channel regulation, where it may regulate and
alter the permeability of gap junctions and hemichannels
[114].
Phosphatases
Other reported partners for connexins include both ser-
ine/threonine and tyrosine phosphatases but the func-
tions of these, although apparently of significance in the
regulation of connexin functions, are yet to be clearly
defined and determined [115]. Most studies have been
performed with Cx43, showing a direct interaction with
several defined and undefined protein phosphatases
[67,116,117], although other connexins are also affected
by various phosphatases. The role of serine/threonine
phosphatases is to limit gap junctional conductance, and
these have been shown using various phosphatase activa-
tors and inhibitors [118]. These effects of phosphatases
have been observed in cardiac myocytes upon conditions
of hypoxia or metabolic starvation [118], and also upon
stimulation of T51B rat liver epithelial cells with EGF
[119]. Similarly, phosphatases have been shown to func-
tion upon treatments of cells with known gap junction
inhibitors such as 18β-glycyrrhetinic acid [120] and 2,3-
Butanedione monoxime [121]. On the other hand, tyro-
sine phosphatases may have a role in enhancing GJIC, as
inhibition of the activity of these enzymes significantly
decreased GJIC in various cell types [122,123].
Other connexin-interacting partners
Among newly-discovered interacting connexin partners,
plasma membrane ion channels, membrane transport
proteins and receptors have been shown to interact
directly or indirectly with connexins, and these include
aquaporin-0 and acetylcholine receptors, among others
[11,124]. Various connexins have also been shown to
interact with calmodulin, which has been implicated in
control of connexin channel gating [11,125]. Further-Cell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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more, the calcium/calmodulin-dependant kinase II
(CaMKII) interacts with and phosphorylates Cx36 and
mediates channel gating in inferior olive neuronal cells
[126]. CaMKII has also been shown to mediate enhanced
gap junctional coupling, mostly through Cx43, in
response to high extracellular K+ in mouse spinal cord
astrocytes [127]. Thus this interaction of connexins with
CaMKII may have a general regulatory role in neuronal
signal transmission, with a role in electrical coupling in
addition to the defined role of CaMKII in chemical synap-
tic transmission [128,129]. Other interactions include
cholesterol, which was shown to interact with gap junc-
tion channels in different ratios during fiber cell differen-
tiation in embryonic chicken lens [130].
Cx43 co-localized with Cox-2 in intestinal adenomas, pro-
viding a possible role for transmission of signals between
stromal and epithelial cells of the tumor, as their expression
localized to myoepithelial cells rather than tumor epithelial
cells. Worth noting is that both Cx43 and Cox-2 are nuclear
-catenin target genes. Together, the implication of  -catenin
regulation and its association with connexins in stromal
cells and how this regulates tumor growth, as adenomas,
raise significant questions that remain unanswered [131].
Recent reports describing localization of Cx43 to mito-
chondria has shown that heat shock protein 90 (Hsp90)
and translocase of the outer mitochondrial membrane
(TOM) are Cx43-interacting partners, which help in trans-
port and insertion of Cx43 in the inner mitochondrial
membrane [132,133]. Other interactions include that with
caveolin-1 which binds to Cx43, and thus provides a poten-
tial framework for the regulation of connexin internaliza-
tion and gap junction degradation [134].
Connexin functions
The increasing interest in connexins has revealed a variety
of novel functions that have been attributed to these pro-
teins. Also of interest is the ever-increasing number of dis-
covered Cx-associated proteins which sheds light on the
complexity of the interactions of these proteins, allowing
connexins to play major roles in many cellular and devel-
opmental functions [11]. In addition, novel discoveries
concerning the activity of connexin hemichannels, as well
as connexins by themselves -independent from both
hemichannels and gap junctions- have increased the
scope of connexin roles in the cell [5,50,135].
Connexins have been shown to play essential roles in nor-
mal development and differentiation of a variety of tissues.
Connexins and their associated proteins are implicated in
mammary gland differentiation, with their levels and phos-
phorylation status being modified throughout the differen-
tiation process, as well as through modulation of their
associated proteins [88,112]. Furthermore, connexins are
central for the normal functioning of body organs, such as
the synchronized contraction of the heart muscle [136-
138], as well as in essential physiological processes such as
tissue inflammation and repair [139]. Also, the loss of con-
nexins, or the existence of mutations affecting their normal
functions, has been implicated in a variety of diseases and
disorders, including cancers [12,13].
Gap junction dependent functions
Gap junction intercellular communication (GJIC) repre-
sents a central conduit of ions, essential metabolites, and
second messengers, such as Ca2+, cAMP, cGMP, and IP3,
between adjacent cells. In past decades, GJ contribution to
the organism homeostasis was construed as passive. How-
ever, studies have shown that gap junctions undergo com-
plex regulation, and play an active role in intercellular
signaling and communication.
Regulation of gap junction function
Gap junction channels, depending on cellular needs and
conditions, alternate between "closed" and "open" con-
formations. These changes are dependent on and are reg-
ulated by various mechanisms including calcium
concentration, pH, transjunctional potential, and protein
phosphorylation. It has been shown that calcium-depend-
ent cellular processes and events might be regulating gap
junctional function, and thus increasing the significance
of connexin interactions with calcium-affected molecules
such as calmodulin [125,126,140]. Moreover, intracellu-
lar pH can also modulate the gating of gap junction chan-
nels. In fact, regulatory sites that respond to pH levels
within gap junctions were found in the intracellular loop
and carboxy terminus domains of the connexin proteins,
a region which shows little sequence homology between
different connexins [141,142]. Hence, differential compo-
sition of the gap junction channels is an important deter-
minant of the response to pH in different cell types [143].
Gap junction conductance (i.e. opening and closure) and
selective permeability to ions and metabolites were also
shown to respond to trans-membrane voltages whereby
large trans-junctional voltages were shown to close the
channels, possibly through the C-terminus interacting
with the pore of the channel [144,145]. This voltage-
mediated regulation of GJIC controls the rate of passage of
ions and molecules (such as cAMP) between cells while
maintaining electrical coupling [146]. In addition,
changes in connexin phosphorylation also affect GJIC.
This effect can occur through a change in the number of
gap junctions at the cell-cell interface by controlling con-
nexin trafficking and degradation, by changing the effi-
ciency of passage of certain molecules through GJs, or by
completely closing or opening the channel for passage of
molecules [147-149].
Significance of gap junctional communication
An array of studies illustrated the important contribution
of GJIC to developmental and regulatory events such as
embryonic growth, bone modeling, alveolar differentia-Cell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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tion, central nervous system signaling and neural function
in the developing central nervous system [150-155]. In
addition, studies pointed to the significant role of GJIC in
maintenance of tissue homeostasis through processes
such as synchronized contraction of cardiac muscle cells
[137].
Tissue differentiation is an essential and continuous proc-
ess, occurring during both embryonic and adult life of the
organism. Various studies have shown that proper GJIC is
essential for the differentiation of various tissues, includ-
ing the mammary gland, lens, bone marrow, sertoli cells,
adipocytes, and other cells and organs [111,156-160].
Previous studies conducted in our laboratory using the
CID-9 heterogeneous mouse mammary cell strain estab-
lished that enhanced GJIC induced partial differentiation
in mammary epithelial cells in the absence of an exoge-
nously provided basement membrane [111]. Interest-
ingly, restoration of gap junctional communication in
colon cancer cells leads to re-establishment of a differen-
tiation phenotype, and the observed re-differentiation of
these cells correlates with increased levels of connexin43
protein and its phosphorylation status [161].
Gap junction mediated communication can exist between
different cell types. Many reports have characterized hete-
rocellular gap junctions in vivo and in vitro, and attrib-
uted important regulatory roles for heterocellular GJIC.
For example, a study by Abraham et al. [150], revealed an
important role of heterocellular gap junctional communi-
cation between Type I and Type II epithelial alveolar cells
to promote epithelial differentiation in the rat lung. Previ-
ous studies have also reported the importance of hetero-
cellular GJIC between cardiac myocytes and surrounding
fibroblasts [162,163], between germ cells and Sertoli cells
in the testis [164], and between neuronal and glial cells in
the nervous system [165]. Moreover, Veitch et al. [166]
recently reported that heterocellular GJ exist in the grow-
ing murine uterus between oocytes and granulosa which
are functionally coupled by homotypic gap junctions
composed of Cx37. In addition, our laboratory has
recently shown that gap junction mediated heterocellular
interaction between myoepithelial-like cells and mam-
mary epithelial cells can induce differentiation of the lat-
ter and leads to concomitant assembly of connexins into
gap junction proteins, and in association with α- and  -cat-
enins and ZO-2 proteins [88].
Gap junctions are also implicated in cell death. This is due
to the "bystander effect" in which gap junctions spread a
death signal between dying cells and those adjoining
them and this may be mediated by Ca2+ influx between
the cells. Such a role of gap junctions in the spread of
injury is observed in the brain following hypoxia-
ischemia [167]. However, gap junctions have also been
shown to "rescue" dying cells by the passage of substrates
such as ATP, glucose, and ascorbic acid, as well as by
inhibiting the passage of cytotoxic agents such as nitric
oxide and others [5,167,168].
Hemichannel dependent functions
Connexin hemichannels have overcome their classifica-
tion as simple structural precursors of gap junctions.
When discovered, hemichannels were thought to be a by-
product of connexin over-expression in certain cell types,
such as oocytes, however successive studies have located
these structures in multiple cell types and in cultured cells,
and even in isolated embryonic stem cells [155,169,170].
Hemichannels are now the subject of many studies that
illustrate their role in various physiological conditions
[50].
Regulation of hemichannel function
Hemichannels are usually closed upon reaching the cell
membrane however their functional state is regulated by
various physiological conditions, due to both intracellular
and extracellular factors [171]. The regulation of
hemichannels is through extracellular changes in ionic
concentration [172,173], membrane depolarization
[174], metabolic inhibition [55,175], and mechanical
stimuli [176].
Roles of hemichannels in cells
Hemichannels function in various aspects of cell life,
including calcium signaling, cell proliferation and death,
as well as the normal functioning and development of var-
ious cell types [50]. For example, neurite outgrowth in
PC12 cells upon stimulation with nerve growth factor was
mediated by hemichannels through the release of ATP
which interacts with purinergic receptors to induce
growth, and possibly affect neuronal differentiation
[177]. In addition, hemichannels are involved in the
movement of NAD+  into and out of cells, reversibly,
which may regulate Ca2+  concentrations through the
CD38 transmembrane glycoprotein [178]. Hemichannels
have also been shown to exist in heart ventricular myo-
cytes, where they have an osmoregulatory role, with both
negative and positive potential impacts with respect to
mycordial infarcts and cardiac physiology [175,179].
Furthermore, hemichannels, similar to gap junctions, play
a role in cell survival and cell death. The effect of
hemichannels in mediating cell death is, similar to GJIC,
observed during ischemic injury in different tissues lead-
ing to significant ionic deregulation in cells [167,180].
Hur  et al. [181] showed that Cx43 hemichannels
enhanced and accelerated cell death following stau-
rosporin treatment. Also, Cx43 hemichannels have been
shown to play a role in the transduction of survival sig-
nals, where treatment of osteocytes and osteoblasts withCell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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biphosphonates leads to hemichannel-mediated activa-
tion of Src kinase and ERK. This effect, mediated both by
the hemichannel pore activity and the C-terminal
domain, leads to ERK activation and attenuation of oste-
oblast cell death [182]. The recent discovery of pannexins,
their hemichannel forming ability, and their co-existence
with connexins in vertebrate cells suggest that data previ-
ously ascribed to connexin hemichannels should be re-
considered [7].
Gap junction- and hemichannel-independent functions of 
connexins
In addition to their multiple roles via exchange of mole-
cules, whether through gap junctions or hemichannels,
connexins by themselves also play various roles inde-
pendent of their channel-forming properties. Such con-
nexin functions are mediated through their multiple
interacting partners, independent of channel formation,
and subsequently lead to the modulation of gene expres-
sion resulting in a wide range of effects [135]. The first of
such reports was by Lee et al., [183] which identified Cx26
as a putative tumor suppressor. This was later confirmed,
showing that Cx26 inhibits cell migration and invasion in
a gap-junction independent mechanism in the MDA-MB-
435 tumor cell line through regulation of β1-integrin and
MMP levels [184], as well as reverses the malignant phe-
notype of MCF-7 breast cancer cells [185]. Furthermore,
the tumor suppressive properties of connexins has been
shown for various connexins, including Cx32, which sup-
pressed growth, invasion, and metastasis of renal cell car-
cinoma cell lines, and this was through various
modulators including Src, tight junction proteins, VEGF
and others [186]. In addition, controlled expression of
Cx43 prevented cell growth independent of its channel-
forming properties, but via the association of its C-termi-
nal domain with proteins such as ZO-1 and c-Src [187]. In
this respect, the ability of connexins to regulate gene
expression independent of their channel functions has
been recently documented [188]. Multiple studies have
shown that alteration of connexin expression, whether
through over-expression or deletion, leads to changes in
gene expression in multiple pathways and cellular func-
tions, including transcription, metabolism, cell/cell and
cell/ECM adhesion, cellular signaling, transport, and cell
cycle and division [189]. One such mechanism is through
connexin-responsive elements (CxRE), where connexins
and gap junctional communication induce differential
recruitment of sp1 and sp3 transcription factors to the
CxRE through the ERK/PI3K pathway, and this regulates
expression of genes having this promoter element
[190,191]. This effect of connexins on gene expression has
also been observed in many studies re-expressing connex-
ins in connexin-deficient tumors, where these affect the
characteristics (growth and tumorigenicity) of the tumor
cells via gap junction-dependent and independent mech-
anisms. This includes regulation of gene expression of
proteins involved in the various processes, such as MMPs
and TIMPs [184], S-phase kinase-associated protein 2
[192], and p21 [193].
Cell differentiation can also be mediated by gap junction-
independent mechanisms of connexins. As such, it has
been shown that Cx45.6 stimulates lens cell differentia-
tion regardless of its channel-forming capability, as the C-
terminal domain of the same connexin is sufficient to
induce differentiation [194]. A study by Xu et al. [195] has
shown that Cx43 mediated directional motility of cardiac
neural crest cells independently from channel-forming
functions and through its association with actin-binding
proteins such as vinculin and drebrin. Similarly, embry-
onic neurons were shown to migrate using Cx43 and
Cx26 gap junctions to provide cytoskeletal contact points
with radial fibers, and this effect did not involve the
exchange of molecules (i.e. functional gap junctions)
between the two cell types at the point of contact [196].
As mentioned earlier, mitochondrial localization of Cx43
[132] is suggested to play vital, though still incompletely
defined roles in various processes [133,197]. For example,
mitochondrial Cx43 is involved in pathological processes
such as hyperhomocysteinemia where it plays a role in
endothelial dysfunction, as well as in cardiac myocytes
where it aids in cardioprotection through enhanced pre-
conditioning response to pharmacological agents such as
diazoxide [197,198]. However, mitochondrial Cx43 may
also contribute to apoptosis of cardiac myocytes, through
enhanced release of Ca2+ and cytochrome C from isolated
mitochondria, following inactivation of GJIC [199]. Fur-
thermore, connexins have been also localized to the
nucleus, and Cx43 has been shown to contain a putative
nuclear targeting sequence in its C-terminal domain
[187,200,201]. In support of this observation, both full
length Cx43 or its C-terminus by itself have been localized
to the nucleus, where they inhibit cell growth [202,203].
Connexin mutations and alterations in disease
Perhaps the significance of connexins in development is
best illustrated by the fact that mouse knockouts of Cx26
[204] and Cx45 [205] are embryonic lethal, whereas Cx43
knockouts die at birth due to congenital cardiac abnor-
malities [206]. Various human diseases have been linked
to connexin gene mutations leading to altered gap junc-
tion, hemichannel, or general connexin functions [13],
and these diseases are divided into seven classes: neuro-
pathic, nonsyndormic and syndromic deafness, skin dis-
eases, cataracts, Oculodentodigital Dysplasia (ODDD),
and idiopathic atrial fibrillation [207]. Cx32 mutations
are associated with Charcot-Marie-Tooth disease, which
affects the central nervous system, leading to reduced
myelination and enhanced excitation of neuronsCell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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[208,209]. Also, mutations in Cx26 may cause either deaf-
ness and skin disease, or deafness alone; while the ectopic
expression of this connexin in the myoepithelium of the
rodent mammary gland disrupts milk ejection (personal
communication, Mina Bissell, LBNL, CA). In addition,
mutations in Cx30, Cx30.3, and Cx31 have also been
implicated in hearing loss and skin disorders [13,210].
Some mutations in Cx26 and Cx32 have been recently
mapped to areas of the transmembrane helices of these
connexins, suggesting that certain disease-causing muta-
tions may decrease the stability of the connexons [211].
Cataracts can be caused by mutations in Cx46 and Cx50
in the lens fiber cells, leading to lens opacities [212,213].
Cx43 mutations are linked to ODDD [13,214], and these
mutations result in non-functional gap junctions and
hemichannels in C6 glioma cells [215]. Some ODDD-
associated Cx43 mutations result in Cx43 C-terminal
truncations, and the skin changes observed in ODDD are
correlated with these mutations [216]. Two recent studies
have shown that ODDD-associated Cx43 mutations lead
to impaired bone differentiation [217] and to delayed
development of the mammary gland as well as defective
milk ejection in response to oxytocin in vivo in a mouse
model of the disease [218]. Idiopathic atrial fibrillation is
caused by mutations in Cx40, and these result in
decreased GJIC either through impaired connexin traffick-
ing or inability to form plaques [219]. It must also be
noted that, in addition to connexin mutation-induced dis-
eases, functional connexins and GJIC may play a role in
spreading injury, as is seen during hypoxia-ischemia
where GJIC spreads neuronal injury [167].
Many connexin-null mouse models of human diseases
have recapitulated disease phenotypes and provided cru-
cial insight into these diseases [207]. Such models include
the Cx32 knockout which served as a model for Charcot-
Marie-Tooth disease, as well as allowed insights into the
role of Cx32 in tumorigenesis [220-222]. In addition, in
mouse null models of connexins 26, 30, and 31, in which
mutations in the human genes are associated with deaf-
ness, only Cx26 and Cx30 null mice resulted in deafness
[223,224], whereas Cx31 null mice did not [225]. This
suggests that connexin-null mouse models may not be the
perfect model for studying human diseases characterized
by connexin point mutations, and as such, a shift in
research towards inserting these point mutations into the
orthologous mouse connexin gene has yielded promising
results [207,226]. This is further confirmed by connexin-
related human diseases, which are lethal, if the relevant
connexin is knocked out in rodents, such as Cx43 and
ODDD. Such diseases can only be studied by generating
mouse models expressing mutated Cx43 [227-229].
Connexins are also implicated in the carcinogenic process,
where disruption of normal connexin functions is a hall-
mark of many tumors [12]. As such, multiple human
breast tumor cell lines exhibit down-regulation of con-
nexin gene expression [230], and deficiency of Cx43 gap
junctions is considered as a marker of breast tumors
[231]. This decreased connexin expression and subse-
quent decrease in gap junctions is also observed in other
tumors, such as gliomas [232]. In contrast to the observed
decrease of connexins in the primary tumors, an increase
in heterocellular gap junctions with endothelial cells is
seen during intravasation and extravasation [233-236]. In
addition, Cx43-mediated GJIC results in increased dia-
pedesis of the breast tumor cell line HBL100 [237]. Gap
junctional communication has also been correlated with
the formation of heterocellular gap junctions between
tumor cells and cells of the secondary tumor site or lymph
nodes [238-240], whereas other studies state that re-
expression of connexins in metastatic tumor cells results
in decreased tumor metastatic potential [184,241].
Another study by Saunders et al. [242] shows that suppres-
sion of MDA-MB-435 tumor cell line metastatic potential
results in increased homocellular GJIC, and also in a
change in the expressed connexin profile. Untreated cells
expressed only Cx32, whereas metastasis-suppressed cells
expressed Cx43. This phenomenon is reversed in HuH7
hepatocellular carcinoma cells in which Cx43 enhanced
tumor cell malignancy through inhibition of Cx32-medi-
ated GJIC and suppression of Cx32 expression altogether
[243], thus, concluding that the impact of GJIC on tumor
metastasis may be dependent on the type of connexin
expressed and the type of cells used.
Conclusion
Proper cellular adhesion and interaction, whether
between cells or with the ECM, is paramount for proper
biological processes. Connexins have important functions
in tissue organization, as they, unlike other junctional
molecules, mediate the direct transfer of molecules from
one cell to another, allowing uniformity and rapid signal
transmission. Understanding the biology and regulatory
mechanisms of gap junctions at transcriptional, transla-
tional, and post-translational levels require further studies
to decipher the breadth and complexity of connexin func-
tions. This includes studying the increasing repertoire of
Cx-interacting proteins, among which are signaling mole-
cules that are crucial for proper development, such as Wnt
signaling via β-catenin among others, and for regulating
important aspects of connexin function and half-life, as in
transport, stability, and degradation.
Furthermore, the recent surge in identifying GJ-independ-
ent functions of connexins, whether in the form of
hemichannels or in channel-independent roles, has given
rise to many novel questions concerning connexin func-
tions in normal physiology. Similarly, this reflects upon
the intricacy of connexin alterations and its possibleCell Communication and Signaling 2009, 7:4 http://www.biosignaling.com/content/7/1/4
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implications in a large variety of diseases. Connexins have
been implicated in several disorders and have even been
shown to play multiple, if sometimes conflicting, func-
tions in tumor initiation and development. The extent of
connexin involvement in cancer, as well as its varied
modes of actions must be "reconciled" and ameliorated
into a functional map describing their role in different
tumor stages. This in turn will yield multiple benefits in
the understanding of cell biology in general, and will also
provide novel targets and/or mediators of therapeutic
strategies for the treatment of different diseases.
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